Literature DB >> 19671066

Peripheral arterial disease is associated with coronary artery spasm as assessed by an intracoronary acetylcholine provocation test.

Kang-Yin Chen1, Seung-Woon Rha, Yong-Jian Li, Kanhaiya L Poddar, Zhe Jin, Yoshiyasu Minami, Lin Wang, Guang-Ping Li, Shigeru Saito, Jae-Hyoung Park, Jin-Oh Na, Cheol Ung Choi, Hong-Euy Lim, Jin-Won Kim, Eung-Ju Kim, Chang-Gyu Park, Hong-Seog Seo, Dong-Joo Oh.   

Abstract

1. Both peripheral arterial disease (PAD) and coronary artery spasm (CAS) are associated with endothelial dysfunction. Thus, a higher incidence of CAS may be expected in patients with PAD. In the present study, we evaluated the incidence and characteristics of CAS in patients with PAD. 2. A total of 78 patients with PAD and 241 age- and gender-matched patients without PAD who had chest pain with normal coronary appearance on coronary angiograms underwent intracoronary acetylcholine (ACh) provocation test. Acetylcholine was injected into the left coronary artery in incremental doses of 20, 50 and 100 microg/min. Significant CAS was defined as a transient > 70% luminal narrowing with concurrent chest pain and/or ST segment changes. 3. Patients with PAD had a significantly higher incidence of ACh-induced significant CAS than those without PAD (60.3 vs 34.0%, respectively P < 0.001), as well as chest pain and ST segment changes during the ACh provocation test. Patients with PAD were more sensitive to lower doses of ACh and had a higher incidence of multivessel spasm than those without PAD. Multivariable logistic analysis showed that age, current smoking, PAD and myocardial bridge were independent predictors of ACh-induced significant CAS. Moreover, of these factors, PAD was the strongest independent predictor (odds ratio 4.25; confidence interval 1.33-13.54; P = 0.014). 4. In patients with chest pain, the presence of arterial disease at another site should still push the clinician towards treating the chest pain as angina, even if the coronary anatomy is normal on a coronary angiogram.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671066     DOI: 10.1111/j.1440-1681.2009.05273.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Prognostic impact of nitrate therapy in patients with myocardial bridge and coexisting coronary artery spasm.

Authors:  Ji Bak Kim; Byoung Geol Choi; Seung-Woon Rha
Journal:  Heart Vessels       Date:  2022-09-13       Impact factor: 1.814

2.  Fatal Vasospasm of the Coronary Arteries in a Patient Undergoing Distal Bypass Surgery and Endovascular Therapy for Threatened Lower Limbs Due to Acute Exacerbation of Peripheral Arterial Disease.

Authors:  Daisuke Takeyoshi; Shinsuke Kikuchi; Keisuke Miyake; Takamitsu Tatsukawa; Daita Kobayashi; Daiki Uchida; Yuya Kitani; Hiroyuki Kamiya; Nobuyoshi Azuma
Journal:  Ann Vasc Dis       Date:  2018-09-25

3.  Impact of Renin-Angiotensin System Inhibitors on Long-Term Clinical Outcomes of Patients With Coronary Artery Spasm.

Authors:  Byoung Geol Choi; Sung Yeon Jeon; Seung-Woon Rha; Sang-Ho Park; Min Suk Shim; Se Yeon Choi; Jae Kyeong Byun; Hu Li; Jah Yeon Choi; Eun Jin Park; Sung-Hun Park; Jae Joong Lee; Sunki Lee; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  J Am Heart Assoc       Date:  2016-07-21       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.